Report

Designing Small-Molecule Switches for Protein-Protein Interactions

See allHide authors and affiliations

Science  16 Jun 2000:
Vol. 288, Issue 5473, pp. 2042-2045
DOI: 10.1126/science.288.5473.2042

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Mutations introduced into human growth hormone (hGH) (Thr175 → Gly–hGH) and the extracellular domain of the hGH receptor (Trp104 → Gly–hGHbp) created a cavity at the protein-protein interface that resulted in binding affinity being reduced by a factor of 106. A small library of indole analogs was screened for small molecules that bind the cavity created by the mutations and restore binding affinity. The ligand 5-chloro-2-trichloromethylimidazole was found to increase the affinity of the mutant hormone for its receptor more than 1000-fold. Cell proliferation and JAK2 phosphorylation assays showed that the mutant hGH activates growth hormone signaling in the presence of added ligand. This approach may allow other protein-protein and protein–nucleic acid interactions to be switched on or off by the addition or depletion of exogenous small molecules.

View Full Text